CD59 and Miyoshi myopathy: In MOLP8 cells, the MM cell line with the highest level of CD59 expression, preincubation with rILYd4 exerted a significantly stronger enhancement of daratumumab- and isatuximab-triggered CDC than preincubation with Ad35K++ (Figure 4a).